RESISTANCE & MODULATION OF LEVAMISOLE RECEPTOR CHANNELS
反抗
基本信息
- 批准号:6626381
- 负责人:
- 金额:$ 21.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-01-01 至 2005-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Ascariasis and hookworm
infections are carried by 1.6 billion people throughout the world and in 2
percent of cases cause loss of life. Anthelmintics, including levamisole and
related drugs (pyrantel and oxantel), are used to combat nematode parasites,
but the development of resistance is a concern. The long-range objective is to
improve and protect human health by protecting the efficacy of anthelmintic
drugs by controlling and reversing resistance. The objective of the application
is to identify mechanisms that regulate the sensitivity of the response of
nematode parasite levamisole receptor channels. Our central hypothesis is that
competing processes (phosphorylation-dephosphorylation) modulate levamisole
responses, and that modification of the processes can produce a decrease or
increase in resistance. We developed this hypothesis on the basis of: 1)
analysis showing consensus regulatory phosphorylation sites on levamisole
receptors; 2) our published and preliminary data showing reduced patency of
levamisole receptor channels in resistant nematodes; 3) strong preliminary data
that shows levamisole responses are reduced by inhibition of protein kinases.
The rationale for the research is that, once mechanisms for regulating
levamisole receptor channels are known, pharmacological approaches can be
formulated to prevent or overcome resistance, and to maintain the efficacy of
levamisole and related anthelmintics. In most experiments we will use
electrophysiological techniques on Ascaris suum to examine the properties of
the receptor channel. Muscle-flap preparations with current- and voltage-clamp
techniques will be used for screening drug effects. We will use muscle-vesicle
preparations and patch-clamp technology to measure effects on gating kinetics
of levamisole receptor channels of nematode parasites. We will pursue two
specific aims to accomplish our current objective: 1) determine mechanisms by
which nematode parasites limit their response (P-open) of receptors, and become
resistant to levamisole; 2) determine mechanisms that increase P-open values of
receptors, in order to reverse resistance to levamisole. We will test our
hypothesis that levamisole resistance can be reversed by increased receptor
phosphorylation in different species of resistant nematodes. The research is
innovative because few groups carry out parasite electrophysiology and others
have not developed nematode parasite muscle-vesicle preparations for
patch-clamp recordings from levamisole receptor channels. We expect the
research to identify mechanisms that decrease levamisole responses (reduce
P-open) so parasites become resistant to levamisole and to demonstrate how this
resistance can be reversed. The research is significant because application of
the results is expected to lead towards methods that will control and overcome
resistance to anthelmintics of the levamisole class.
描述(改编自申请人的摘要):蛔虫和钩虫
全世界有16亿人感染,
%的病例造成生命损失。驱虫药,包括左旋咪唑和
相关药物(噻嘧啶和oxantel),用于对抗线虫寄生虫,
但耐药性的发展是一个问题。长期目标是
通过保护驱虫药的功效来改善和保护人类健康
药物通过控制和逆转耐药性。申请的目的
是确定调节反应敏感性的机制,
线虫寄生虫左旋咪唑受体通道。我们的核心假设是,
竞争过程(磷酸化-去磷酸化)调节左旋咪唑
反应,并且修改过程可以减少或
增加阻力。我们提出这一假设的基础是:1)
显示左旋咪唑上共有调节磷酸化位点的分析
受体; 2)我们发表的和初步的数据显示,
抗性线虫中的左旋咪唑受体通道; 3)强有力的初步数据
这表明左旋咪唑的反应被蛋白激酶的抑制所降低。
这项研究的基本原理是,一旦调节机制
左旋咪唑受体通道是已知的,药理学方法可以
配制以预防或克服耐药性,并维持
左旋咪唑和相关的驱虫剂。在我们将使用的大多数实验中
电生理技术检测猪蛔虫的特性
受体通道。电流钳和电压钳肌瓣制备
技术将用于筛选药物效果。我们将使用肌肉囊泡
用于测量对门控动力学影响的制剂和膜片钳技术
左旋咪唑受体通道。我们将追捕两名
实现我们当前目标的具体目标:1)确定机制,
这种线虫寄生虫限制了它们对受体的反应(P-开放),
抗左旋咪唑; 2)确定增加P-open值的机制,
受体,以逆转对左旋咪唑的耐药性。我们将测试
左旋咪唑耐药性可通过受体增加而逆转假说
在不同种类的抗性线虫中的磷酸化。这项研究是
创新,因为很少有小组进行寄生虫电生理学和其他
还没有开发出线虫寄生虫肌肉囊泡制剂,
左旋咪唑受体通道的膜片钳记录。我们预计
研究确定降低左旋咪唑反应的机制(减少
P-open),因此寄生虫对左旋咪唑产生耐药性,并证明这是如何
阻力可以逆转。该研究具有重要意义,
这些结果有望导致控制和克服
对左旋咪唑类驱虫药的抗性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard John Martin其他文献
Richard John Martin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard John Martin', 18)}}的其他基金
Slo-1K channels, TRP-2 channels, emodepside and diethylcarbamazine in Filaria
丝虫中的 Slo-1K 通道、TRP-2 通道、艾默德苷和二乙基卡马嗪
- 批准号:
10264892 - 财政年份:2020
- 资助金额:
$ 21.68万 - 项目类别:
Slo-1K channels, TRP-2 channels, emodepside and diethylcarbamazine in Filaria
丝虫中的 Slo-1K 通道、TRP-2 通道、艾默德苷和二乙基卡马嗪
- 批准号:
10089614 - 财政年份:2020
- 资助金额:
$ 21.68万 - 项目类别:
Slo-1K channels, TRP-2 channels, emodepside and diethylcarbamazine in Filaria
丝虫中的 Slo-1K 通道、TRP-2 通道、艾默德苷和二乙基卡马嗪
- 批准号:
10683137 - 财政年份:2020
- 资助金额:
$ 21.68万 - 项目类别:
Slo-1K channels, TRP-2 channels, emodepside and diethylcarbamazine in Filaria
丝虫中的 Slo-1K 通道、TRP-2 通道、艾默德苷和二乙基卡马嗪
- 批准号:
10468815 - 财政年份:2020
- 资助金额:
$ 21.68万 - 项目类别:
Diethylcarbamazine, Emodepside and SLO-1 K Channels of Filaria
二乙基卡马嗪、艾莫德苷和丝虫的 SLO-1 K 通道
- 批准号:
9807551 - 财政年份:2019
- 资助金额:
$ 21.68万 - 项目类别:
Membrane Ion-channels in Helminth Parasites: Anthelmintic Resistance and Sites of
蠕虫寄生虫中的膜离子通道:驱虫药耐药性和位点
- 批准号:
8203993 - 财政年份:2011
- 资助金额:
$ 21.68万 - 项目类别:
Pharmacological Diversity of nAChRs in Clade III Nematodes: Levamisole receptors
进化枝 III 线虫中 nAChR 的药理学多样性:左旋咪唑受体
- 批准号:
8501957 - 财政年份:2001
- 资助金额:
$ 21.68万 - 项目类别:
Pharmacological Diversity of nAChRs in Clade III Nematodes: Levamisole receptors
进化枝 III 线虫中 nAChR 的药理学多样性:左旋咪唑受体
- 批准号:
8786864 - 财政年份:2001
- 资助金额:
$ 21.68万 - 项目类别:
相似海外基金
Development of inhibitors of P. falciparum cGMP dependent protein kinase (PfPKG) for malaria chemoprevention
开发用于疟疾化学预防的恶性疟原虫 cGMP 依赖性蛋白激酶 (PfPKG) 抑制剂
- 批准号:
9386266 - 财政年份:2017
- 资助金额:
$ 21.68万 - 项目类别:
Development of inhibitors of P. falciparum cGMP dependent protein kinase (PfPKG) for malaria chemoprevention
开发用于疟疾化学预防的恶性疟原虫 cGMP 依赖性蛋白激酶 (PfPKG) 抑制剂
- 批准号:
9751740 - 财政年份:2017
- 资助金额:
$ 21.68万 - 项目类别:
cGMP-dependent protein kinase I as a new target against stroke
cGMP依赖性蛋白激酶I作为抗中风的新靶点
- 批准号:
9346117 - 财政年份:2016
- 资助金额:
$ 21.68万 - 项目类别:
cGMP-dependent protein kinase I as a new target against stroke
cGMP依赖性蛋白激酶I作为抗中风的新靶点
- 批准号:
9240123 - 财政年份:2016
- 资助金额:
$ 21.68万 - 项目类别:
cGMP-dependent protein kinase and iron metabolism
cGMP依赖性蛋白激酶和铁代谢
- 批准号:
248173116 - 财政年份:2014
- 资助金额:
$ 21.68万 - 项目类别:
Research Grants
Genetic analyses of allelic variation in cGMP-dependent protein kinase and troponin-1 and their effects on behaviour
cGMP 依赖性蛋白激酶和肌钙蛋白-1 等位基因变异的遗传分析及其对行为的影响
- 批准号:
371554-2009 - 财政年份:2013
- 资助金额:
$ 21.68万 - 项目类别:
Discovery Grants Program - Individual
Genetic analyses of allelic variation in cGMP-dependent protein kinase and troponin-1 and their effects on behaviour
cGMP 依赖性蛋白激酶和肌钙蛋白-1 等位基因变异的遗传分析及其对行为的影响
- 批准号:
371554-2009 - 财政年份:2012
- 资助金额:
$ 21.68万 - 项目类别:
Discovery Grants Program - Individual
The roles of cGMP-dependent protein kinase and its novel substrates in nervous system
cGMP依赖性蛋白激酶及其新型底物在神经系统中的作用
- 批准号:
23780106 - 财政年份:2011
- 资助金额:
$ 21.68万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Genetic analyses of allelic variation in cGMP-dependent protein kinase and troponin-1 and their effects on behaviour
cGMP 依赖性蛋白激酶和肌钙蛋白-1 等位基因变异的遗传分析及其对行为的影响
- 批准号:
371554-2009 - 财政年份:2011
- 资助金额:
$ 21.68万 - 项目类别:
Discovery Grants Program - Individual
Genetic analyses of allelic variation in cGMP-dependent protein kinase and troponin-1 and their effects on behaviour
cGMP 依赖性蛋白激酶和肌钙蛋白-1 等位基因变异的遗传分析及其对行为的影响
- 批准号:
371554-2009 - 财政年份:2010
- 资助金额:
$ 21.68万 - 项目类别:
Discovery Grants Program - Individual